Cboe Global Markets Inc. (CBOE) Insider Trading
Insiders sold $2.33M and bought nothing on the open market.
30% of the selling was scheduled in advance under 10b5-1 plans. Director Edward J. Fitzpatrick sold $1.13M on Feb 18, 23% of their stake, outside a plan. The last open-market buy by an executive or director was in May 2022.
Get an email when CBOE's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Aug 12 | Janet P Froetscher Director | Sold10b5-1 plan | 937 | $278.95 | $261k | 6.8% | Form 4 |
| May 18 | Janet P Froetscher Director | Sold10b5-1 plan | 1,223 | $358.09 | $438k | 8.1% | Form 4 |
| Feb 23 | Allen Wilkinson SVP, CHIEF ACCOUNTING OFFICER | SoldNo plan | 248 | $292.79 | $73k | 38% | Form 4 |
| Feb 18 | Alexander Matturri Jr Director | SoldNo plan | 1,500 | $285.36 | $428k | 24% | Form 4 |
| Feb 18 | Edward J. Fitzpatrick Director | SoldNo plan | 3,947 | $285.87 | $1.13M | 23% | Form 4 |
| Sep 2, 2025 | Christopher A Isaacson EVP, COO | Sold10b5-1 plan | 5,000 | $236.66 | $1.18M | 12% | Form 4 |
| Jun 9, 2025 | Christopher A Isaacson EVP, COO | Sold10b5-1 plan | 5,000 | $221.37 | $1.11M | 11% | Form 4 |
| May 23, 2025 | Catherine R Clay EVP, GLOBAL DERIVATIVES | Sold10b5-1 plan | 3,598 | $226.58 | $815k | 62% | Form 4 |
| Mar 12, 2025 – Mar 13, 2025 | Jill R Goodman Director | SoldNo plan 2 parts | 2,684 | $208.86 average | $561k | 19% | Form 4 |
| Feb 24, 2025 | Allen Wilkinson SVP, CHIEF ACCOUNTING OFFICER | SoldNo plan | 228 | $211.12 | $48k | 48% | Form 4 |
| Feb 20, 2025 | Adam Inzirillo EVP, DATA VANTAGE | SoldNo plan | 200 | $209.67 | $42k | 9.1% | Form 4 |
| Feb 20, 2025 | Dave Howson EVP, GLOBAL PRESIDENT | Sold10b5-1 plan 3 parts | 5,659 | $208.65 average | $1.18M | 41% | Form 4 |
| Feb 12, 2025 | Dave Howson EVP, GLOBAL PRESIDENT | Sold10b5-1 plan | 11,036 | $206.01 | $2.27M | 58% | Form 4 |
| Feb 10, 2025 | Catherine R Clay EVP, GLOBAL DERIVATIVES | SoldNo plan | 3,000 | $211.85 | $636k | 41% | Form 4 |
| Feb 10, 2025 | Adam Inzirillo EVP, DATA VANTAGE | SoldNo plan | 80 | $211.66 | $17k | 6.2% | Form 4 |
| Dec 13, 2024 | Adam Inzirillo EVP, DATA VANTAGE | SoldNo plan | 25 | $200.43 | $5k | 1.9% | Form 4 |
- Aug 1210b5-1 planJanet P FroetscherDirector · sold 937 at $278.95$261k6.8% of stake
- May 1810b5-1 planJanet P FroetscherDirector · sold 1,223 at $358.09$438k8.1% of stake
- Feb 23No planAllen WilkinsonSVP, CHIEF ACCOUNTING OFFICER · sold 248 at $292.79$73k38% of stake
- Feb 18No planAlexander Matturri JrDirector · sold 1,500 at $285.36$428k24% of stake
- Feb 18No planEdward J. FitzpatrickDirector · sold 3,947 at $285.87$1.13M23% of stake
- Sep 2, 202510b5-1 planChristopher A IsaacsonEVP, COO · sold 5,000 at $236.66$1.18M12% of stake
- Jun 9, 202510b5-1 planChristopher A IsaacsonEVP, COO · sold 5,000 at $221.37$1.11M11% of stake
- May 23, 202510b5-1 planCatherine R ClayEVP, GLOBAL DERIVATIVES · sold 3,598 at $226.58$815k62% of stake
- Mar 12, 2025 – Mar 13, 2025No planJill R GoodmanDirector · sold 2,684 at avg $208.86$561k19% of stake
- Feb 24, 2025No planAllen WilkinsonSVP, CHIEF ACCOUNTING OFFICER · sold 228 at $211.12$48k48% of stake
- Feb 20, 2025No planAdam InzirilloEVP, DATA VANTAGE · sold 200 at $209.67$42k9.1% of stake
- Feb 20, 202510b5-1 planDave HowsonEVP, GLOBAL PRESIDENT · sold 5,659 at avg $208.65$1.18M41% of stake
- Feb 12, 202510b5-1 planDave HowsonEVP, GLOBAL PRESIDENT · sold 11,036 at $206.01$2.27M58% of stake
- Feb 10, 2025No planCatherine R ClayEVP, GLOBAL DERIVATIVES · sold 3,000 at $211.85$636k41% of stake
- Feb 10, 2025No planAdam InzirilloEVP, DATA VANTAGE · sold 80 at $211.66$17k6.2% of stake
- Dec 13, 2024No planAdam InzirilloEVP, DATA VANTAGE · sold 25 at $200.43$5k1.9% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Related stocks: Security & Commodity Brokers, Dealers, Exchanges & Services
Spot a number that looks wrong? Check it in CBOE's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing CBOE
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.